Mark Duval

536 total citations
25 papers, 465 citations indexed

About

Mark Duval is a scholar working on Virology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Mark Duval has authored 25 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Virology, 15 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Immunology. Recurrent topics in Mark Duval's work include HIV Research and Treatment (19 papers), Monoclonal and Polyclonal Antibodies Research (15 papers) and Immune Cell Function and Interaction (8 papers). Mark Duval is often cited by papers focused on HIV Research and Treatment (19 papers), Monoclonal and Polyclonal Antibodies Research (15 papers) and Immune Cell Function and Interaction (8 papers). Mark Duval collaborates with scholars based in United States, Israel and Canada. Mark Duval's co-authors include Lisa A. Cavacini, Marshall R. Posner, David Kuhrt, Kenneth H. Mayer, James E. Robinson, Xiaocong Yu, Joseph P. Eder, Shi-Hua Xiang, Mukesh Kumar and Joseph Sodroski and has published in prestigious journals such as The Journal of Immunology, Journal of Virology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Mark Duval

25 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Duval United States 14 250 231 177 115 102 25 465
Rosanne Wisniewolski United States 8 124 0.5× 158 0.7× 164 0.9× 212 1.8× 58 0.6× 10 470
Mark Melchers Netherlands 11 230 0.9× 286 1.2× 59 0.3× 144 1.3× 99 1.0× 17 519
R Khiroya United States 11 98 0.4× 271 1.2× 105 0.6× 137 1.2× 38 0.4× 14 502
Patrick Skog United States 12 314 1.3× 703 3.0× 201 1.1× 299 2.6× 101 1.0× 15 952
P Roben United States 8 438 1.8× 453 2.0× 543 3.1× 337 2.9× 175 1.7× 11 920
Jordana Griffiths United Kingdom 6 92 0.4× 413 1.8× 193 1.1× 147 1.3× 32 0.3× 6 684
Susan M. Cleveland United States 13 111 0.4× 128 0.6× 41 0.2× 186 1.6× 62 0.6× 19 462
S K Sikder United States 10 96 0.4× 156 0.7× 158 0.9× 177 1.5× 61 0.6× 12 384
P T Schellekens Netherlands 10 211 0.8× 490 2.1× 64 0.4× 79 0.7× 94 0.9× 13 712
Daniella Livnat United States 9 251 1.0× 280 1.2× 110 0.6× 154 1.3× 136 1.3× 14 514

Countries citing papers authored by Mark Duval

Since Specialization
Citations

This map shows the geographic impact of Mark Duval's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Duval with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Duval more than expected).

Fields of papers citing papers by Mark Duval

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Duval. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Duval. The network helps show where Mark Duval may publish in the future.

Co-authorship network of co-authors of Mark Duval

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Duval. A scholar is included among the top collaborators of Mark Duval based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Duval. Mark Duval is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duval, Mark, Claudia Carbone, Smita Jaiswal, et al.. (2018). Human Anti–HIV-1 gp120 Monoclonal Antibodies with Neutralizing Activity Cloned from Humanized Mice Infected with HIV-1. The Journal of Immunology. 202(3). 799–804. 6 indexed citations
2.
Yu, Xiaocong, et al.. (2016). Overcoming the Constraints of Anti-HIV/CD89 Bispecific Antibodies That Limit Viral Inhibition. Journal of Immunology Research. 2016. 1–5. 8 indexed citations
3.
Yu, Xiaocong, et al.. (2012). Impact of IgA constant domain on HIV-1 neutralizing function of monoclonal antibody F425-A1g8 (75.12). The Journal of Immunology. 188(1_Supplement). 75.12–75.12. 2 indexed citations
4.
Yu, Xiaocong, et al.. (2012). Neutralization of HIV by Milk Expressed Antibody. JAIDS Journal of Acquired Immune Deficiency Syndromes. 62(1). 10–16. 4 indexed citations
5.
Duval, Mark, Christopher J. Lewis, John F. Nomellini, et al.. (2011). Enhanced Neutralization of HIV by Antibodies Displayed on the S-Layer of Caulobacter crescentus. Antimicrobial Agents and Chemotherapy. 55(12). 5547–5552. 15 indexed citations
6.
Yu, Xiaocong, et al.. (2010). Neutralization of HIV by Milk Expressed Antibody. Clinical Immunology. 135. S90–S90. 1 indexed citations
7.
8.
Miranda, Luis R., et al.. (2007). The Neutralization Properties of a HIV-Specific Antibody Are Markedly Altered by Glycosylation Events Outside the Antigen-Binding Domain. The Journal of Immunology. 178(11). 7132–7138. 26 indexed citations
9.
Cavacini, Lisa A., Kailash C. Bhol, Mong-Shang Lin, et al.. (2006). Pathogenic human monoclonal antibody against desmoglein 3. Clinical Immunology. 120(1). 68–75. 39 indexed citations
10.
Liu, Fangbing, Mukesh Kumar, Qiangzhong Ma, et al.. (2005). Human Single-Chain Antibodies Inhibit Replication of Human Immunodeficiency Virus Type 1 (HIV-1). AIDS Research and Human Retroviruses. 21(10). 876–881. 5 indexed citations
11.
Cavacini, Lisa A., Mark Duval, Charles Wood, et al.. (2005). Dichotomy in cross‐clade reactivity and neutralization by HIV‐1 sera: Implications for active and passive immunotherapy. Journal of Medical Virology. 76(2). 146–152. 3 indexed citations
12.
Cavacini, Lisa A., David Kuhrt, Mark Duval, Kenneth H. Mayer, & Marshall R. Posner. (2003). Binding and Neutralization Activity of Human IgG1 and IgG3 from Serum of HIV-Infected Individuals. AIDS Research and Human Retroviruses. 19(9). 785–792. 31 indexed citations
13.
Liu, Fangbing, Pablo Lopez‐Bergami, Mark Duval, et al.. (2003). Expression and Functional Activity of Isotype and Subclass Switched Human Monoclonal Antibody Reactive with the Base of the V3 Loop of HIV-1 gp120. AIDS Research and Human Retroviruses. 19(7). 597–607. 24 indexed citations
14.
Cavacini, Lisa A., et al.. (2003). Conformational changes in env oligomer induced by an antibody dependent on the V3 loop base. AIDS. 17(5). 685–689. 45 indexed citations
15.
Cavacini, Lisa A., Mark Duval, James E. Robinson, & Marshall R. Posner. (2002). Interactions of human antibodies, epitope exposure, antibody binding and neutralization of primary isolate HIV-1 virions. AIDS. 16(18). 2409–2417. 35 indexed citations
16.
Cavacini, Lisa A., Adam V. Wisnewski, David C. Montefiori, et al.. (1999). A Human Anti-HIV Autoantibody Enhances EBV Transformation and HIV Infection. Clinical Immunology. 93(3). 263–273. 9 indexed citations
17.
Cavacini, Lisa A., et al.. (1999). Minimal Incidence of Serum Antibodies Reactive with Intact Primary Isolate Virions in Human Immunodeficiency Virus Type 1-Infected Individuals. Journal of Virology. 73(11). 9638–9641. 18 indexed citations
18.
Cavacini, Lisa A., Matthew H. Samore, John G. Gambertoglio, et al.. (1998). Phase I Study of a Human Monoclonal Antibody Directed against the CD4-Binding Site of HIV Type 1 Glycoprotein 120. AIDS Research and Human Retroviruses. 14(7). 545–550. 49 indexed citations
19.
Cavacini, Lisa A., et al.. (1995). Influence of heavy chain constant regions on antigen binding and HIV-1 neutralization by a human monoclonal antibody. The Journal of Immunology. 155(7). 3638–3644. 26 indexed citations
20.
Cavacini, Lisa A., et al.. (1994). Effect of antibody valency on interaction with cell-surface expressed HIV-1 and viral neutralization.. The Journal of Immunology. 152(5). 2538–2545. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosanne Wisniewolski Breakdown of academic impact, for papers by Mark Melchers Breakdown of academic impact, for papers by R Khiroya Breakdown of academic impact, for papers by Patrick Skog Breakdown of academic impact, for papers by P Roben Breakdown of academic impact, for papers by Jordana Griffiths Breakdown of academic impact, for papers by Susan M. Cleveland Breakdown of academic impact, for papers by S K Sikder Breakdown of academic impact, for papers by P T Schellekens Breakdown of academic impact, for papers by Daniella Livnat
Rankless by CCL
2026